PST-611

BIOLOGICAL2 trials

Sponsors

Eyevensys

Conditions

Age - Related Macular Degeneration (AMD)Dry Age Related Macular DegenerationGeographic Atrophy

Phase 1

A Safety and Tolerability Clinical Trial of PST-611 in Dry Age-related Macular Degeneration

CompletedNCT07024732

EyevensysDry Age Related Macular Degeneration

Start: 2025-06-23End: 2026-04-07Updated: 2026-07-13

Phase 2

An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy

Not yet recruitingNCT07705568

EyevensysAge - Related Macular Degeneration (AMD), Geographic Atrophy

Start: 2026-09-01End: 2028-06-01Target: 24Updated: 2026-07-16